BIONOTE Overview

  • Year Founded
  • 2003

Year Founded

  • Status
  • Public

  • Employees
  • 328

Employees

  • Stock Symbol
  • 377740

Stock Symbol

  • Investments
  • 6

  • Share Price
  • $3.39
  • (As of Friday Closing)

BIONOTE General Information

Description

BioNote Inc is a manufacturer of veterinary diagnostic test product and biocontent. The company is engaged in research, develop, manufacturing and distribute diagnostic reagent products with high clinical importance.

Contact Information

Website
www.bionote.co.kr
Formerly Known As
Animal Genetics
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Corporate Office
  • 30, Samsung 1-ro 4-gil
  • Hwaseong, Gyeonggi
  • South Korea
+82
Primary Industry
Diagnostic Equipment
Other Industries
Laboratory Services (Healthcare)
Stock Exchange
KRX
Corporate Office
  • 30, Samsung 1-ro 4-gil
  • Hwaseong, Gyeonggi
  • South Korea
+82

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

BIONOTE Stock Performance

As of 13-Nov-2026, BIONOTE’s stock price is $3.39. Its current market cap is $342M with 101M shares.

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$3.39 $3.45 $2.75 - $4.34 $342M 101M 55.5K -$0.85

BIONOTE Financials Summary

As of 30-Jun-2026, BIONOTE has a trailing 12-month revenue of $87.1M.

In Thousands,
USD 		TTM 30-Jun-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 64,576 142,955 55,447 12,672
Revenue 87,102 83,143 75,328 68,898
EBITDA (81,527) (65,173) 45,211 (95,844)
Net Income (86,605) (61,482) 40,501 (15,677)
Total Assets 1,046,112 1,080,474 1,152,200 1,236,027
Total Debt 2,081 2,536 2,669 3,824
Public Fundamental Data provided by Morningstar, Inc. disclaimer

BIONOTE Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore BIONOTE‘s full profile, request access.

Request a free trial

BIONOTE Patents

  • 23

    Total Documents Applications and Grants

  • Total Patents Families

  • 9

    Granted

  • 2

    Pending

  • Expiring in next 12 mo

BIONOTE Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026187166-A1 Canine antibody fc variant and use thereof Pending 05-Mar-2025
EP-4169946-A1 Antibodies binding specifically to nt-probnp and use thereof Active 25-Oct-2021
EP-4169946-B1 Antibodies binding specifically to nt-probnp and use thereof Active 25-Oct-2021
US-12493048-B2 Antibodies binding specifically to nt-probnp and use thereof Active 25-Oct-2021
US-20230288436-A1 Antibodies binding specifically to nt-probnp and use thereof Active 25-Oct-2021 G01N33/74
To view BIONOTE’s complete patent history, request access »

BIONOTE Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

BIONOTE Investments (6)

BIONOTE’s most recent deal was a Secondary Transaction - Private with CTCBio for . The deal was made on 27-Oct-2025.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
CTCBio 27-Oct-2025 Secondary Transaction - Private Pharmaceuticals
CTCBio 03-Feb-2025 Corporate Pharmaceuticals
Centenaire 07-Feb-2023 Early Stage VC Discovery Tools (Healthcare)
Centenaire 22-Mar-2022 Early Stage VC Discovery Tools (Healthcare)
NA Vaccine Institute 18-Nov-2021 Early Stage VC Drug Discovery
You’re viewing 5 of 6 investments. Get the full list »

BIONOTE ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Healthcare

Industry

Rank

Percentile

Medical Devices

Subindustry

Rank

Percentile

To view BIONOTE’s complete esg history, request access »

BIONOTE FAQs

  • When was BIONOTE founded?

    BIONOTE was founded in 2003.

  • Where is BIONOTE headquartered?

    BIONOTE is headquartered in Hwaseong, South Korea.

  • What is the size of BIONOTE?

    BIONOTE has 328 total employees.

  • What industry is BIONOTE in?

    BIONOTE’s primary industry is Diagnostic Equipment.

  • Is BIONOTE a private or public company?

    BIONOTE is a Public company.

  • What is BIONOTE’s stock symbol?

    The ticker symbol for BIONOTE is 377740.

  • What is the current stock price of BIONOTE?

    As of 13-Nov-2026 the stock price of BIONOTE is $3.39.

  • What is the current market cap of BIONOTE?

    The current market capitalization of BIONOTE is $342M.

  • What is BIONOTE’s current revenue?

    The trailing twelve month revenue for BIONOTE is $87.1M.

  • What is BIONOTE’s annual earnings per share (EPS)?

    BIONOTE’s EPS for 12 months was -$0.85.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process